Generics 28

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Granisetron manufacturers

28 products found

Filters

28 products found

granisetron

Ampoules 0.1 mg/ml, 1 mg/ml - 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Austria , Brazil , Canada , Chile , Colombia , Denmark , Finland , France , Germany , Greece , Ireland , Israel , Italy , Jordan , Kuwait , Lebanon , Mexico , Netherlands , Norway , Panama , Portugal , Sweden , Switzerland , Turkey , United Kingdom , Venezuela
Comments
Worldwide excluding the below mentioned countries: Saudi Arabia, UAE, Yemen, Bahrain, Oman, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore, Sri Lanka, Vietnam, New Zealand, Australia, Thailand, Taiwan, Philippines Libya, Kenya, Egypt.
Manufacturer #8501

A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe, North America, and Asia for 100+ years. The company's production lines are cGMP-compliant. The main dosage forms include injectable and oral solid. The company possesses manufacturing facilities in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

granisetron

Vials 0.1 mg/ml, 1 mg/ml - 1 ml, 4 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #8501

A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe, North America, and Asia for 100+ years. The company's production lines are cGMP-compliant. The main dosage forms include injectable and oral solid. The company possesses manufacturing facilities in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

granisetron

Ampoules, injection 1 mg/1 ml, 3 mg/3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
GB
Manufacturer #14955
It is part of the pharmaceutical and medicine manufacturing industry and is located in Europe. This site generates more than $300 million in revenue. The corporate family consists of nearly 20 different companies.

Manufacturer usually replies in 5 days

granisetron

Tablets, film coated 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
GB
Manufacturer #14955
It is part of the pharmaceutical and medicine manufacturing industry and is located in Europe. This site generates more than $300 million in revenue. The corporate family consists of nearly 20 different companies.

Manufacturer usually replies in 5 days

granisetron

Ampoules, injection 1 mg/1 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 2 days

granisetron

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

granisetron

Solution for injection/infusion 3 mg/3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Unavailable markets
Vietnam
Manufacturer #9488
It is a company that has grown up in Europe's pharmaceutical industry, with a product portfolio that includes licensed and contract-manufactured medications. The company is open to collaborating with other local and international companies while carrying out their subcontracting and co-marketing projects. It is dedicated to continuing to add value and work for human health by playing an active role in the local market and around the world. They have more than 30 million in product production.  

Manufacturer usually replies in 5 days

granisetron

Solution for injection 1 mg/1ml, 1 mg/5 ml, 3 mg/ml, 4 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

granisetron

Vials, injection 1 mg/ml - 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

granisetron

Injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20656

Manufacturer usually replies in 2 days

granisetron

Injection 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

granisetron

Ampoules, injection 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19124

Manufacturer usually replies in 2 days

granisetron

Tablets 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

granisetron

Injection 1 mg/ml, 3 mg/3 ml - 1 ml, 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20982

Manufacturer usually replies in 8 days

granisetron

Injection 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

granisetron

Injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

granisetron

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19203

Manufacturer usually replies in 6 days

granisetron

Injection 3 mg / 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18736
It was founded in the 2000s. The main aim of the position itself in the market as a company dedicated to the research, development, manufacturing, marketing, and distribution of new generation specialized generic and biosimilar medicines.

Manufacturer usually replies in 7 days

granisetron

Tablets 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

granisetron

Vials, injection 1 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

Want to view all 28 products? Create your free account today!

Granisetron Manufacturers

Markets of interest

Granisetron is an antiemetic and antinauseant for cancer chemotherapy patients. As a serotonin receptor (5HT-3 selective) antagonist that has been used the substance blocks the actions of chemicals in the body that can trigger nausea and vomiting. The medication is used to prevent nausea and vomiting that may be caused by medicine to treat cancer (chemotherapy or radiation). The substance is available for sale in the form of ampoules, tablets, film-coated, tablets, vials, solution for infusion, solution for injection/infusion, from manufacturers in various countries including Y. The drug is provided by a wide range of Granisetron suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Granisetron manufacturers and distributors are based in India, China, and Turkey.

Licensing and brand names

Granisetron was approved by the FDA for use in the USA in 2020. In 2011 under the trade name Kytril, the medication was approved by the EMA in the European Union. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Granisetron Hydrochloride, Kytril. One of the most popular branded versions of Granisetron is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from China, India, South Korea, Spain, Malta, Taiwan, and the United States, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Granisetron as an active ingredient.

Target supply price

The wholesale acquisition cost for granisetron intravenous solution (1 mg/mL) is around $18 for a supply of 1 milliliter(s). The retail price of 10 film-coated tablets (1Mg/film-coated tablet) of the substance in Europe reaches 30.74 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Granisetron manufacturers and suppliers that you are looking for. You can also find the dossier status of Granisetron and the GMP approvals of the different variants of the medication. The product description of all Granisetron suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Granisetron is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.